Table 4 Satisfaction regarding skin sensitivity in the operated breast
Factor | Satisfied | Not satisfied | OR (95% CI) | OR (95% CI)a | OR (95% CI)b |
|---|---|---|---|---|---|
n (%) | n (%) | ||||
Age (years) | |||||
<50 | 33 (16.6) | 13 (17.8) | 1 | 1 | 1 |
≥50–<65 | 78 (39.2) | 36 (49.3) | 1.17 (0.55–2.49) | 1.15 (0.54–2.48) | 1.15 (0.49–2.71) |
≥65 | 88 (44.2) | 24 (32.9) | 0.69 (0.32–1.52) | 0.61 (0.27–1.36) | 0.59 (0.25–1.44) |
BMI (kg/m2) | |||||
<25 | 93 (47.0) | 26 (35.6) | 1 | 1 | 1 |
≥25–<30 | 62 (31.3) | 31 (42.5) | 1.79 (0.97–3.30) | 1.99 (1.06–3.72) | 2.07 (1.04–4.12) |
≥30 | 43 (21.7) | 16 (21.9) | 1.33 (0.65–2.73) | 1.51 (0.72–3.16) | 1.78 (0.78–4.03) |
Missing | 1 | ||||
Breast volume (ml)c | |||||
<500 | 88 (44.7) | 31 (43.1) | 1 | 1 | |
≥500 | 109 (55.3) | 41 (56.9) | 1.07 (0.62–1.84) | 1.05 (0.56–1.98) | |
Missing | 2 | 1 | |||
Tumour size (mm)c | |||||
<15 | 106 (53.3) | 22 (30.1) | 1 | 1 | 1 |
≥15 | 93 (46.7) | 51 (69.9) | 2.64 (1.49–4.68) | 2.43 (1.36–4.34) | 1.88 (1.01–3.48) |
Specimen weight (g)c | |||||
<63 | 106 (53.3) | 30 (41.1) | 1 | 1 | |
≥63 | 93 (46.7) | 43 (58.9) | 1.63 (0.95–2.81) | 1.65 (0.92–2.94) | |
EPBVEd (%) | |||||
<10 | 67 (34.0) | 17 (23.6) | 1 | 1 | 1 |
≥10–<20 | 107 (54.3) | 40 (55.6) | 1.47 (0.77–2.81) | 1.49 (0.77–2.90) | 1.15 (0.56–2.36) |
≥20 | 23 (11.7) | 15 (20.8) | 2.57 (1.11–5.96) | 2.80 (1.18–6.65) | 1.84 (0.73–4.63) |
Missing | 2 | 1 | |||
Axillary clearance | |||||
No | 171 (85.9) | 53 (73.6) | 1 | 1 | 1 |
Yes | 28 (14.1) | 19 (26.4) | 2.19 (1.13–4.23) | 2.07 (1.05–4.07) | 1.57 (0.75–3.28) |
Missing | 1 | ||||
Re-excision | |||||
No | 191 (96.0) | 63 (86.3) | 1 | 1 | 1 |
Yes | 8 (4.0) | 10 (13.7) | 3.80 (1.43–10.02) | 4.14 (1.53–11.20) | 3.86 (1.34–11.06) |
Infection | |||||
No | 190 (95.5) | 63 (86.3) | 1 | 1 | 1 |
Yes | 9 (4.5) | 10 (13.7) | 3.35 (1.30–8.62) | 3.58 (1.34–9.60) | 3.26 (1.18–9.03) |
Radiotherapy | |||||
No | 32 (16.1) | 5 (5.5) | 1 | 1 | 1 |
Yes | 167 (83.9) | 69 (94.5) | 3.31 (1.13–9.70) | 2.87 (0.96–8.61) | 1.73 (0.53–5.68) |
Chemotherapy | |||||
No | 180 (90.5) | 60 (82.2) | 1 | 1 | |
Yes | 19 (9.5) | 13 (17.8) | 2.05 (0.96–4.41) | 1.94 (0.86–4.36) | |
Hormonal therapy | |||||
No | 94 (47.2) | 26 (35.6) | 1 | 1 | |
Yes | 105 (52.8) | 47 (64.4) | 1.62 (0.93–2.82) | 1.56 (0.89–2.74) | |
Quadrant | |||||
UOQ | 103 (52.0) | 36 (49.3) | 1 | 1 | |
LOQ | 39 (19.7) | 14 (19.2) | 1.03 (0.50–2.11) | 1.03 (0.49–2.15) | |
LIQ | 16 (8.1) | 7 (9.6) | 1.25 (0.48–3.29) | 1.37 (0.51–3.69) | |
UIQ | 38 (19.2) | 16 (21.9) | 1.21 (0.60–2.42) | 1.13 (0.56–2.30) | |
Central | 2 (1.0) | 0 (0.0) | – | – | |
Missing | 1 | ||||